Florida Cancer Specialists

Latest from Florida Cancer Specialists


FCS Adds New In-House, Precision Oncology Capabilities

July 27, 2022

Florida Cancer Specialists & Research Institute announced the formation of additional precision oncology capabilities and resources comprised of geneticists, informatics specialists, and database technologies that will enhance patient care through comprehensive analysis of molecular data.

FCS’ Walcker Outlines His Hopes for Successor Model to OCM

July 01, 2022

In the second of 2 parts, Nathan H. Walcker, MBA, CEO of Florida Cancer Specialists & Research Institute (FCS), discusses what he’d like value-based care to look like going forward. CMS ended the Oncology Care Model (OCM) yesterday after 6 years and has invited practices to apply for a successor model, the Enhancing Oncology Model.

FCS’ Walcker Explains Value-Based Cancer Care

June 30, 2022

In the first of 2 parts, Nathan H. Walcker, MBA, CEO of Florida Cancer Specialists & Research Institute (FCS), discusses the future of value-based care for the practice as the Oncology Care Model comes to an end today. This week, CMS announced it will launch a successor model.

FCS Expanding Employment, Educational Opportunities For Underserved Students

May 13, 2022

Florida Cancer Specialists & Research Institute (FCS) announced a partnership with Strayer University’s Grads to Work program that will help prepare a diverse population of students for job opportunities and support them while they continue their education.

Nathan H. Walcker on Expectations for Stakeholders Attending Tampa IVBM Meeting

April 27, 2022

Nathan H. Walcker, MBA, chief executive officer, Florida Cancer Specialists & Research Institute (FCSRI), discusses what guests can expect at the in-person Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by FCSRI.